SIC
VIR icon

SJS Investment Consulting’s Vir Biotechnology VIR Stock Holding History

SJS Investment Consulting’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.38K Buy
332
+322
+3,220% +$3.06K ﹤0.01% 1551
2026
Q1 		$90 Buy
+10
New +$80 ﹤0.01% 2155
2024
Q3 		– Sell
-12
Closed -$107 – 1716
2024
Q2 		$107 Hold
12
– – ﹤0.01% 1578
2024
Q1 		$122 Hold
12
– – ﹤0.01% 1554
2023
Q4 		$121 Buy
12
+3
+33% +$27 ﹤0.01% 1536
2023
Q3 		$85 Buy
9
+3
+50% +$43 ﹤0.01% 1562
2023
Q2 		$148 Buy
+6
New +$151 ﹤0.01% 1459

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
SAI
Savvy Advisors Inc New York $4.71B AUM 25.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

SJS Investment Consulting's VIR Position: Q2 2026 in Review

SJS Investment Consulting increased its Vir Biotechnology (VIR) stake by 3,220% in Q2 2026, buying an estimated $3.06K and bringing the position to 332 shares worth $3.38K. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

SJS Investment Consulting first reported a position in VIR in Q2 2023 and has held it in 7 quarters since. 82 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • SJS Investment Consulting held 332 shares of Vir Biotechnology worth $3.38K as of Q2 2026.
  • SJS Investment Consulting bought 322 Vir Biotechnology shares in Q2 2026, an estimated $3.06K.
  • Vir Biotechnology made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1551 holding.
  • SJS Investment Consulting first reported a position in Vir Biotechnology in Q2 2023 and has held it in 7 quarters since.
  • 82 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.